Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Interferon-alpha × Clear all

Sponsor

Conditions

Melanoma 4 Carcinoma, Renal Cell 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Kidney Neoplasms 3 Pancreatic Neoplasms 2 Multiple Myeloma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia 2 Warts 1 Small Cell Lung Carcinoma 1 Recurrence 1 Papilloma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lung Neoplasms 1 HIV Infections 1 Colorectal Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡